A Basis for Reduced Chemical Library Inhibition of Firefly Luciferase Obtained from Directed Evolution

被引:59
作者
Auld, Douglas S. [1 ]
Zhang, Ya-Qin [1 ]
Southall, Noel T. [1 ]
Rai, Ganesha [1 ]
Landsman, Marc [1 ]
MacLure, Jennifer [1 ]
Langevin, Daniel [1 ]
Thomas, Craig J. [1 ]
Austin, Christopher P. [1 ]
Inglese, James [1 ]
机构
[1] NIH, Chem Genom Ctr, Bethesda, MD 20892 USA
关键词
THROUGHPUT SCREENING ASSAYS; PROTEIN-KINASE; BIOLUMINESCENT ASSAYS; IDENTIFICATION; TRANSCREENER(TM); FLUORESCENCE; ACTIVATION; DISCOVERY; DRUGABILITY; MECHANISM;
D O I
10.1021/jm8014525
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We measured the "druggability" of the ATP-dependent luciferase derived from the firefly Photuris pennsylvanica that was optimized using directed evolution (Ultra-Glo, Promega). Quantitative high-throughput screening (qHTS) was used to determine IC(50)S of 198899 samples against a formulation of Ultra-Glo luciferase (Kinase-Glo). We found that only 0.1 % of the Kinase-Glo inhibitors showed an IC(50) < 10 mu M compared to 0.9% found from a previous qHTS against the firefly luciferase from Photinus pyralis (lucPpy). Further, the maximum affinity identified in the lucPpy qHTS was 50 nM, while for Kinase-Glo this value increased to 600 nM. Compounds with interactions stretching outside the luciferin binding pocket were largely lost with Ultra-Glo luciferase. Therefore, Ultra-Glo luciferase will show less compound interference when used as an ATP sensor compared to lucPpy. This study demonstrates the power of large-scale quantitative analysis of structure-activity relationships (> 100K compounds) in addressing important questions such as a target's druggability.
引用
收藏
页码:1450 / 1458
页数:9
相关论文
共 46 条
[1]   A specific mechanism for nonspecific activation in reporter-gene assays [J].
Auld, Douglas S. ;
Thorne, Natasha ;
Nguyen, Dac-Trung ;
Inglese, James .
ACS CHEMICAL BIOLOGY, 2008, 3 (08) :463-470
[2]   Characterization of chemical libraries for luciferase inhibitory activity [J].
Auld, Douglas S. ;
Southall, Noel T. ;
Jadhav, Ajit ;
Johnson, Ronald L. ;
Diller, David J. ;
Simeonov, Anton ;
Austin, Christopher P. ;
Inglese, James .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (08) :2372-2386
[3]   A high throughput luminescent assay for glycogen synthase kinase-3β inhibitors [J].
Baki, Andrea ;
Bielik, Attila ;
Molnar, Laszlo ;
Szendrei, Gyorgyi ;
Keseru, Gyorgy M. .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2007, 5 (01) :75-83
[4]  
Cali JJ, 2008, EXPERT OPIN DRUG MET, V4, P103, DOI [10.1517/17425255.4.1.103, 10.1517/17425255.4.1.103 ]
[5]   Luminogenic cytochrome P450 assays [J].
Cali, James J. ;
Ma, Dongping ;
Sobol, Mary ;
Simpson, Daniel J. ;
Frackman, Susan ;
Good, Troy I. ;
Daily, William J. ;
Liu, David .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) :629-645
[6]   Structure-based maximal affinity model predicts small-molecule druggability [J].
Cheng, Alan C. ;
Coleman, Ryan G. ;
Smyth, Kathleen T. ;
Cao, Qing ;
Soulard, Patricia ;
Caffrey, Daniel R. ;
Salzberg, Anna C. ;
Huang, Enoch S. .
NATURE BIOTECHNOLOGY, 2007, 25 (01) :71-75
[7]   Nanoliter dispensing for uHTS using pin tools [J].
Cleveland, PH ;
Koutz, PJ .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2005, 3 (02) :213-225
[8]  
Comley J., 2006, DRUG DISCOVERY WORLD, V7, P27
[9]   The minimum significant ratio: A statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies [J].
Eastwood, BJ ;
Farmen, MW ;
Iversen, PW ;
Craft, TJ ;
Smallwood, JK ;
Garbison, KE ;
Delapp, NW ;
Smith, GF .
JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (03) :253-261
[10]   A structural biology view of target drugability [J].
Egner, Ursula ;
Hillig, Roman C. .
EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (04) :391-401